CA2125854A1 - Imidazoquinazoline compounds and their preparation and use - Google Patents

Imidazoquinazoline compounds and their preparation and use

Info

Publication number
CA2125854A1
CA2125854A1 CA002125854A CA2125854A CA2125854A1 CA 2125854 A1 CA2125854 A1 CA 2125854A1 CA 002125854 A CA002125854 A CA 002125854A CA 2125854 A CA2125854 A CA 2125854A CA 2125854 A1 CA2125854 A1 CA 2125854A1
Authority
CA
Canada
Prior art keywords
compound
cyclopropyl
quinazoline
imidazo
oxadiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002125854A
Other languages
English (en)
French (fr)
Inventor
Holger C. Hansen
Marit Kristiansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2125854A1 publication Critical patent/CA2125854A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002125854A 1991-12-20 1992-12-18 Imidazoquinazoline compounds and their preparation and use Abandoned CA2125854A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK912042A DK204291D0 (da) 1991-12-20 1991-12-20 Heterocykliske forbindelser deres fremstilling og anvendelse
DK2042/91 1991-12-20

Publications (1)

Publication Number Publication Date
CA2125854A1 true CA2125854A1 (en) 1993-07-08

Family

ID=8109668

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002125854A Abandoned CA2125854A1 (en) 1991-12-20 1992-12-18 Imidazoquinazoline compounds and their preparation and use

Country Status (12)

Country Link
EP (1) EP0619820A1 (enrdf_load_stackoverflow)
JP (1) JPH07502278A (enrdf_load_stackoverflow)
AU (1) AU673814B2 (enrdf_load_stackoverflow)
CA (1) CA2125854A1 (enrdf_load_stackoverflow)
DK (1) DK204291D0 (enrdf_load_stackoverflow)
FI (1) FI942963A7 (enrdf_load_stackoverflow)
IL (1) IL104099A (enrdf_load_stackoverflow)
NO (1) NO942301L (enrdf_load_stackoverflow)
NZ (1) NZ246558A (enrdf_load_stackoverflow)
TW (1) TW211568B (enrdf_load_stackoverflow)
WO (1) WO1993013103A1 (enrdf_load_stackoverflow)
ZA (1) ZA929770B (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
CN1052724C (zh) * 1996-07-01 2000-05-24 瑞安大药厂股份有限公司 新的光学活性的2,3－二氢咪唑并[1,2－c]喹唑啉衍生物及其制备方法和用途
KR100864364B1 (ko) 2005-12-13 2008-10-17 주식회사 엘지화학 신규한 이미다조퀴나졸린 유도체, 이의 제조방법 및 이를이용한 유기전기소자
EP2125750B1 (en) 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
DK2324018T3 (da) 2008-07-25 2013-10-14 Boehringer Ingelheim Int Cykliske inhibitorer af 11 beta-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
CA2813671A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
JP2023545196A (ja) * 2020-10-16 2023-10-26 シャンハイ ドーァ ノボ ファーマテック カンパニー，リミティド 三複素環誘導体、その医薬組成物及び使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297099C (en) * 1985-10-17 1992-03-10 Frank Watjen Quinazoline compounds and their preparation and use
DK155524C (da) * 1987-03-18 1989-09-11 Ferrosan As Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse
DK443589D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug

Also Published As

Publication number Publication date
IL104099A0 (en) 1993-05-13
EP0619820A1 (en) 1994-10-19
AU3344893A (en) 1993-07-28
NZ246558A (en) 1995-07-26
ZA929770B (en) 1994-06-17
FI942963L (fi) 1994-06-20
WO1993013103A1 (en) 1993-07-08
JPH07502278A (ja) 1995-03-09
IL104099A (en) 1996-07-23
AU673814B2 (en) 1996-11-28
DK204291D0 (da) 1991-12-20
NO942301L (no) 1994-08-19
TW211568B (enrdf_load_stackoverflow) 1993-08-21
FI942963A0 (fi) 1994-06-20
FI942963A7 (fi) 1994-06-20
NO942301D0 (no) 1994-06-17

Similar Documents

Publication Publication Date Title
JP6105578B2 (ja) 複素環式プロテインキナーゼ阻害剤
EP3233845B1 (en) Parg inhibitory compounds
EP1237891B1 (en) Heterocyclic dihydropyrimidines as potassium channel inhibitors
CA2125854A1 (en) Imidazoquinazoline compounds and their preparation and use
JP5134548B2 (ja) 過剰増殖性疾患の処置のためのＥｒｂＢＩ型受容体チロシンキナーゼ阻害剤としてのＮ４−フェニルキナゾリン−４−アミン誘導体および関連化合物
KR20100041771A (ko) 6-시클로아미노-3-(피리다진-4-일)이미다조[1,2-ｂ]피리다진 및 그의 유도체, 그의 제조법 및 치료 용도
KR20170093967A (ko) Parg 억제제로서 2,4-다이옥소-퀴나졸린-6-설폰아미드 유도체
CS231958B2 (en) Manufacturing process of new heteroclic compoundes
CZ20014244A3 (cs) Benzotiazinonové a benzoxazinonové sloučeniny
BG107750A (bg) ПИРОЛОТРИАЗИНОВИ СЪЕДИНЕНИЯ И ИЗПОЛЗВАНЕТО ИМ КАТО ИНХИБИТОРИ НА р38 КИНАЗА
JP2018529725A (ja) キナーゼ阻害剤としての縮合ピラゾール誘導体
SK33995A3 (en) Imidazodiazepines
IE883347L (en) Imidazoquinoxaline compounds and their preparation and use
AU627181B2 (en) Imidazoquinoxaline compounds and their preparation and use
IE862734L (en) Quinazolines
US7144887B2 (en) Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
US5276028A (en) Imidazoquinoxaline compounds
US5371080A (en) Imidazoquinazoline compounds and their use
WO1992000298A1 (en) Heterocyclic compounds and their preparation and use
IE59495B1 (en) Oxadiazolylimidazobenzodiazepines, process for their preparation and pharmaceutical compositions
ES2371450T3 (es) Dihidropirimidinas heterocíclicas como inhibidores de los canales de potasio.
HK40041458A (en) Heterocyclic protein kinase inhibitors
HK40001531A (en) Heterocyclic protein kinase inhibitors
HK40001531B (en) Heterocyclic protein kinase inhibitors

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19991220